Patterns of Use, Safety, and Effectiveness of Targeted Therapies in First-Line Treatment of Metastatic Colorectal Cancer According to Age: The STROMBOLI Cohort Study-Reference-Cited by-同舟云学术

Patterns of Use, Safety, and Effectiveness of Targeted Therapies in First-Line Treatment of Metastatic Colorectal Cancer According to Age: The STROMBOLI Cohort Study

Published:2019-03 Issue:1 Volume:18 Page:e150-e162
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Gouverneur Amandine,Coutureau Juliette^ORCID,Jové Jérémy,Rouyer Magali,Grelaud Angela,Duc Sophie,Gérard Stéphane,Smith Denis,Ravaud Alain^ORCID,Droz Cécile,Bernard Marie-Agnès,Lassalle Régis,Forrier-Réglat Annie,Noize Pernelle,Smith D.,Tubiana-Mathieu N.,Michel P.,Guimbaud R.,Becouarn Y.,Viret F.,Guimbaud R.,Larregain-Fournier D.,Botreau Y.,Texereau P.,Auby D.,Gautier-Felizot L.,Loury-Larivière I.,Brudieux E.,Cany L.,Lecaille C.,Jaubert D.,Guichard P.,Bernard O.,Vives L.,Taoubi N.,Martinez M.,Burki F.,Roque I.,Thouveny F.,Gaspard M.H.

Funder

National Clinical Research Programme

French Ministry of Health

Roche SAS

Merck Santé s.a.s.

AstraZeneca

Bayer

Baxter

Biogen

BMS

Helsinn

Lilly